🇺🇸 FDA
Patent

US 7348153

Method for identifying and designing immunogenic peptides

granted A61PA61P35/00A61P35/04

Quick answer

US patent 7348153 (Method for identifying and designing immunogenic peptides) held by The Board of Regents of the University of Texas System expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00, A61P35/04, A61P37/04